|ESVC – European Society of Veterinary Cardiology
||Cilostazol as medical treatment of bradycardia of cardiac origin in dogs
||Smartphone-based 6-lead ECG: a new device for electrocardiographic recording in dogs
||Correlation of serum N-terminal pro B-type natriuretic peptide with pulmonary hypertension in heartworm-infected dogs during adulticide treatment
||The good, the bad and the breeder - Development of genetic HCM-variants in cat populations from routine testing in the last 10 years
||Assessment of precordial R-peak time in dogs with left sided volume overload secondary to myxomatous mitral valve disease and dilated cardiomyopathy
||Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease
||Clinical findings and outcome in 27 cats with transient myocardial thickening
||Associations between thoracic radiographic changes and severity of pulmonary hypertension diagnosed via Doppler echocardiography in dogs with heartworm disease (Dirofilaria immitis).
||Clinical presentation and survival in dogs with acquired atrial septal defect secondary to myxomatous mitral valve disease
||Echocardiographic classification of dogs with aortic stenosis: potential utility of a novel staging system
||Serum proteomic profiles in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease
||The impact of intravenous medetomidine and vatinoxan on echocardiographic evaluation of dogs with ACVIM stage B1 mitral valve disease
||Percutaneous closure of patent ductus arteriosus with the Vet-PDA Occluder® device in dog
||How do practicing veterinarians treat stage B and C myxomatous mitral valve degeneration in dogs?
||Ratio of tricuspid annular plane systolic excursion on systolic pulmonary arterial pressure as a prognostic factor in canine pre-capillary pulmonary hypertension
||The effect of anesthesia drug on cardiac function parameters in cats
||Aortic insufficiency in dogs and cats: A retrospective study of clinical characteristics, echocardiographic findings, and prognosis in non-infectious and non-congenital cases
||Respiratory rate and breathing pattern in dogs and cats admitted to the intensive care unit at two small animal hospitals in Sweden.
||Temporal cardiomegaly induced by non-cardiogenic respiratory distress in dogs with myxomatous mitral valve disease
||Association of decreased bodyweight-independent tricuspid annular plane systolic excursion (TAPSE) measured in M-mode with clinical signs of heart failure and cardiac death in dogs with pre-capillary pulmonary hypertension.
||Respiratory Sinus Arrhythmia Dynamics in Dogs with Various Classes of Naturally Occurring Myxomatous Mitral Valve Disease
||Proteomics and coagulation markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy
||Clinical and echocardiographic findings in dogs with heartworm caval syndrome
||The prognostic value of circulating cardiac and renal biomarkers in dogs with myxomatous mitral valve disease
|SCH – Society of Comparative Hepatology
||A retrospective study investigating the grade and temporal progression of feline gall bladder sludge and association with concurrent disease
||Biliary hamartoma: a case series in small animals
|ESVCP – European Society of Veterinary Clinical Pathology
||Performance of predicted ionized calcium (piCa) in dogs with ambiguous prediction interval results
||Is the erythrocyte sedimentation rate (ESR) a reliable inflammatory marker in cats?
||Frequency of healthy dogs with normal creatinine measurement and IRIS stage II categorisation using a point-of-care analyser
||Immune-modulatory effect of doxycycline on canine neutrophils: Impact on neutrophil extracellular trap formation, reactive oxygen species production and killing efficiency on Staphylococcus aureus
|ESVNU – European Society of Veterinary Nephrology and Urology
||Capillary electrophoresis in urine from healthy cats: comparison with canine patterns
||One-step, non-surgical placement of permanent low-profile cystostomy tubes in nine dogs
||Comparison between urine protein-creatinine ratios of samples obtained from healthy cats at home and in hospital.
||The prevalence of disease in diagnosis-naïve older cats presented for health screening to two UK-based veterinary clinics
||Ultrasound assessments of cats associated with polycystic kidney disease caused by feline PKD1 genetic mutation
||Association of Fibroblast growth factor-23 (FGF-23) with parameters of renal dysfunction in dogs and cats
||Alterations in canine magnesium levels caused by Leishmania infantum-induced chronic renal disease
||Effect of subcutaneous bypass (SUB) on proteinuria in cats with ureteral obstruction.
||Development of Cardiorenal Syndrome type IV (Chronic renocardiac syndrome) in cats attended to a nephrology service
|ESCG – European Society of Comparative Gastroenterology
||Serial evaluation of the effects of antibiotic use on the intestinal microbiome in kittens using the feline dysbiosis index
||Serial measurement of serum specific pancreatic lipase and trypsin-like immunoreactivity concentrations in dogs and cats with diabetes mellitus
||Comparative study of video capsule endoscopy findings in dogs with chronic enteropathy and in healthy dogs
||Characterization of the intestinal microbiome of dogs with inflammatory brain disease compared to dogs with non-inflammatory brain disease and healthy control dogs
||Interrelation between microbiota and intraepithelial and lamina propria duodenal T-lymphocytes in dogs with inflammatory bowel disease
||Evaluation of fecal microbiota transplantation as adjunct management of cats with chronic enteropathies in a controlled, blinded, randomized clinical trial
||Chronic enteropathy and emotional health in dogs - a prospective comparative pilot study
||Overview of faecal pathogens isolated from faeces of French young cats and dogs using PCR technique over a year (2022)
||Serial measurement of serum-specific pancreatic lipase and trypsin-like immunoreactivity concentrations in cats during treatment for chronic enteropathy
||Relationship between 1,2-O-dilauryl-rac-glycero glutaric acid-(6’-methylresorufin) ester (DGGR) lipase activity and clinical signs in dogs with chronic gastrointestinal signs over time
||Prevalence of duodenal lymphangiectasia in French Bulldogs with obstructive airway syndrome undergoing endoscopic examination of the respiratory tract and upper digestive tract: retrospective study in 29 cases (2021-2022)
||Holter analysis in dogs with acute and chronic diarrhea
||Psyllium husk powder increases defecation frequency and fecal score, bulk and moisture in healthy cats
||Fecal microbiota transplantation in dogs with tylosin responsive enteropathy - A proof of concept study
||Characterization of underlying causes, treatment approaches, short and long-term outcome in young cats with chronic recurrent gastrointestinal signs
||Effect of various storage conditions on bacteria viability in fecal microbiota transplantation preparations
||Fecal proteolytic activities in dogs with chronic inflammatory enteropathies
||Protein-losing enteropathy in Pugs: a different form of disease?
||Mortality rate and associated characteristics prior to hospital discharge in dogs with protein-losing enteropathy
|ISCAID – International Society for Companion Animal Infectious Diseases
||Seroprevalence of toxoplasma-specific antibodies in European cats suspected of toxoplasmosis
||Serum cardiac troponin I as an indicator of myocarditis in dogs diagnosed with leptospirosis
||Dynamics of selected inflammatory markers during treatment of feline infectious peritonitis
||The association between immune-mediated thrombocytopenia diagnosed by flow cytometry and canine monocytic ehrlichiosis
||Impact of DNA extraction methods and culture-independent approaches on canine lung mycobiota analysis
||Characterisation of Clinical Bleeding Diathesis, and Laboratory Haemostatic Aberrations and Survival in 180 Dogs (2005-2019) Naturally Infected with Angiostrongylus vasorum
||Resistance of Leishmania infantum to allopurinol in dogs in Europe – a digital droplet PCR assay for quantifying S-adenosylmethionine synthetase (METK) gene copy number
||Prevalence and risk factors for Mycoplasma spp. positivity in cat blood donor units from Portugal, Spain and Belgium in 2022: retrospective study on 7573 blood donations from 4121 healthy donor cats
||A multivalent vaccine against Lyme borreliosis applied to dogs using different vaccination schedules: characterization of the humoral immune response
||Leptospira in dogs in Hong Kong: serology and urinary shedding
||Leishmania infantum specific IL-2 production after oclacitinib and ciclosporin treatments in ex vivo stimulated canine blood
||Evaluation of complementary stem cell therapy in the treatment of kidney disease secondary to canine leishmaniasis
||Advantage of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for bacterial identification in cats with pyothorax
||The effect of oclacitinib and ciclosporin A on IL-17a production against Leishmania infantum stimulated canine blood
||Serum amino acid profile in canine sepsis and its relationship with survival
||Comparison of Real-Time PCR and culture of bronchoalveolar lavage fluid in dogs for the detection of Bordetella bronchiseptica infection: a retrospective study of 12 cases.
||Co-infections and risk factors in stray cats in Gran Canaria (Spain): Dirofilaria immitis, Bartonella henselae, feline leukemia and feline immunodeficiency.
|ESVIM – European Society of Veterinary Internal Medicine
||Characterisation of brachycephalic obstructive airway syndrome in cats using barometric whole-body plethysmography
||Dorsomedial nasopharyngeal masses with a benign appearance in dogs: a retrospective study of 99 cases (2019-2022).
||Incidence and characterization of aerophagia in dogs using videofluoroscopic swallow studies
||Spectrographic analysis of lung sound for identifying visual characteristics of crackles in dogs
||Clinical evaluation and endoscopic classification of gastrointestinal findings in 220 dogs with brachicephalic syndrome.
||Heinz Body Formation in 13 Multimorbid Dogs following Metamizole Administration
||Root cause analysis of medication-related incidents in small animal veterinary practices: An Analysis of Incident Reports
||Effects of short-term oral 25-hydroxyvitamin D supplementation on leukocyte cytokine production in healthy dogs
||Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases
||Clinical efficacy of feline recombinant interferon-omega as an additional agent in refractory feline chronic gingivostomatitis
||Determination of the plasma proteome of healthy dogs using Liquid Chromatography - Mass spectrometry.
||Pharmacodynamics of Standard and Low Dose Once Daily Esomeprazole in Healthy, Medium to Large Breed Dogs
||Current epidemiology and therapeutic trends of feline chronic rhinitis - a retrospective study
||Owners’ perspective about the use of mirtazapine transdermal ointment in cats – a survey-based study
||Outcome and prognostic factors in dogs diagnosed with immune-mediated thrombocytopenia in Ireland (2009-2020)
||Pimenta da Silva
||evaluation of association between hemoparasite infection risk and blood phenotype, gender and breed in potential feline blood donors of portugal and spain
||Prevalence, age and disease associations in Yorkshire terriers with increased blood urea nitrogen
||Clinical and imaging findings, bacterial isolates and antimicrobial resistance in 14 dogs with tracheal and/or bronchial collapse: a retrospective study of 14 cases.
||Clinical manifestations, endoscopic findings and outcome of palatine tonsil crypt foreign bodies in dogs: 7 cases (2020-2022)
|ESVONC – European Society of Veterinary Oncology
||Implementation of an Elekta Infinity linear accelerator with advanced treatment technology
||Platelet count changes in cats with lymphoma following repeated vincristine administration.
||Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
||Incidence of elevated serum symmetric dimethylarginine in Australian dogs with multicentric large B-cell lymphoma
||Retrospective evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: a multi-institutional study
||Thermographic assessment of soft tissue sarcomas in dogs.
||Feasibility of using flow cytometric analysis of Ki-67 expression in canine cutaneous mast cell tumours - a pilot study
||Round cell tumours and the feline tarsus: a fatal attraction
||Surgery and Adjuvant Electrochemotherapy Compared to Surgery Alone for Treatment of Canine Soft Tissue Sarcomas
||Evaluation of staging in 504 dogs with aggressive peripheral nodal B cell lymphoma across 16 Oncology referral centres.
||a retrospective clinico-pathologic study of 37 dogs with urethral carcinoma (2012 - 2022)
||A retrospective study of clinical outcome in response to short chemotherapy protocol for feline intermediate- and large cell lymphoma
||Erythrocyte and platelet characteristics as indicators of metastasis in canine carcinomas and sarcomas
||Is Chemotherapy Useful In Feline Mammary Tumours?
||Garcia-de la Virgen
||Toceranib (Palladia®) as a first line therapy in macroscopic canine oral squamous cell carcinoma: a case series
||Evaluation of the CLOP protocol as induction in canine non-indolent T-cell lymphoma
|ESVE – European Society of Veterinary Endocrinology
||Radioimmunoassay (RIA) enabled thyroid profile in healthy dogs: effect of age, sex, breed, and diet
||Machine-learning as a diagnostic tool for naturally occurring hypercortisolism in dogs
||A prospective study to examine the natural variation of interstitial glucose levels in healthy adult dogs utilising a continuous glucose monitoring system.
||Signalment, clinicopathological findings, management practices and occurrence of comorbidities in cats with diabetes mellitus in Germany: prospective study of 148 cases
||Thyroid hormone concentrations in healthy Irish Setters and Rhodesian Ridgeback dogs: a diagnostic comparison
||Interpretation of screening tests for hypercortisolism by first-opinion western european veterinary surgeons
||Perceptions of first-opinion veterinarians and owners in Switzerland about treatment of feline hyperthyroidism
||Urinary aldosterone to creatinine ratio and fractional excretion of sodium and potassium in healthy cats, cats with primary hyperaldosteronism and cats with secondary hyperaldosteronism
||The effect of treatment modality on changes in quality of life in hyperthyroid cats
||Hypercortisolism in cats in relation with diabetes mellitus: clinical and laboratory abnormalities, blood pressure and survival under trilostane treatment.
||Addison Detect: a machine learning predictive model web application to assess canine hypoadrenocorticism likelihood using signalment and routine bloodwork results
||Longitudinal evaluation of blood pressure in cats treated for hyperthyroidism.
||Feline hypersomatotropism without concurrent diabetes mellitus: 21 cases (2014-2023)
||Stress or success – hair cortisol concentrations in relation to cat characteristics, health and reproductive status in cats
||evaluation of urinary corticoid-to-creatinine ratio using a canine-specific chemiluminescent cortisol assay (immulite 2000) in the diagnosis of canine hypercortisolism
||Circulating concentrations of betatrophin in dogs with diabetes mellitus
||Comparison of symmetric dimethylarginine, plasma aldosterone concentration, renin activity and systolic blood pressure between diabetic and non-diabetic cats with hypersomatotropism
||Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with chronic kidney disease
||Healthy Canine and Human Derived Pituitary Gland Organoids Exhibit Comparable Cellular Complexity and Hormone Secretion
||Canine hypoadrenocorticism – evaluation of aldosterone concentration and thyroid autoantibodies in dogs
||Urinary steroid profiling using liquid chromatography-tandem mass spectrometry for the diagnosis of canine Cushing’s syndrome
||Normal thyroid values in 3-week and 8-week-old healthy kittens
||Desoxycorticosterone pivalate (DOCP) pharmacodynamics in dogs with hypoadrenocorticism